Drug Trial Radar · NCT00651118
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Last checked: Nov 19, 2026Latest source record: Sep 26, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
832
Actual
Start
Mar 2008
Primary completion
Jun 2008
Study completion Jul 2008
Sponsor
- Lead sponsor
- Meda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Apr 2, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)
Conditions
- Seasonal Allergic Rhinitis
Interventions
PlaceboDrug
placebo
azelastine HclDrug
azelastine Hcl 548 mcg
azelastineHcl / fluticasone propionateDrug
azelastine Hcl 548 mcg / fluticasone propionate 200 mcg
fluticasone propionateDrug
fluticasone propionate 200 mcg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in 12-hour Reflective Total Nasal Symptom Score (rTNSS)Time frame: days 1 to 14
Locations
43 sites in 1 country. Site status is shown where the registry gives one.
Allergy, Asthma and Immunology Associates
Scottsdale, Arizona
Clinical Research Center
Encinitas, California
Allergy Research Foundation
Los Angeles, California
Southern California Research
Mission Viejo, California
Peninsula Research Associates
Rolling Hills Estates, California
Allergy and Asthma Medical Group and Research Center
San Diego, California
Bensch Research Associates
Stockton, California
Allergy and Asthma Clinical Research, Inc.
Walnut Creek, California
Storms Clinical Research Institute
Colorado Springs, Colorado
Colorado Allergy and Asthma Centers
Denver, Colorado
Colorado Allergy and Asthma Centers
Lakewood, Colorado
Clinical Research Atlanta
Atlanta, Georgia
Aeroallergy Research Laboratories of Savannah
Savannah, Georgia
Clinical Research Atlanta
Stockbridge, Georgia
Sneeze, Wheeze and Itch Associates
Normal, Illinois
Kansas City Allergy and Asthma
Overland Park, Kansas
Northeast Medical Research Associates
North Dartmouth, Massachusetts
Clinical Research Institute
Minneapolis, Minnesota
Clinical Research Institute
Plymouth, Minnesota
The Clinical Research Center
St Louis, Missouri
Allergy, Asthma and Immunology Associates
Lincoln, Nebraska
The Asthma and Allergy Center
Papillion, Nebraska
Atlantic Research Center
Ocean City, New Jersey
Research Asthma, Sinus and Allergy Centers
Warren Township, New Jersey
AAIR Research Center
Rochester, New York
Island Medical Research
Rockville Centre, New York
North Carolina Clinical Research
Raleigh, North Carolina
Bernstein Clinical Research Center
Cincinnati, Ohio
Allergy Clinic of Tulsa
Tulsa, Oklahoma
Allergy Asthma and Dermatology Research
Lake Oswego, Oregon
Allergy and Consultants of NJ/PA
Collegeville, Pennsylvania
Allergy and Clinical Immunology Associates
Pittsburgh, Pennsylvania
Asthma and Allergy Research Associate
Upland, Pennsylvania
National Allergy, Asthma and Urticaria of Charleston
Charleston, South Carolina
East Tennesse Center for Clinical Research
Knoxville, Tennessee
Allergy and Asthma Associates
Austin, Texas
Allergy and Asthma Center of Austin
Austin, Texas
AARA Research Center
Dallas, Texas
Jane Lee, MD, PA Research Center
Dallas, Texas
Central Texas Health Research
New Braunfels, Texas
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.